Form 4: CompoSecure CRO Plans Future Stock Sale Under 10b5-1
Insider Trading Report (Form 4)
CompoSecure's Chief Revenue Officer, Amanda Gourbault, has filed a Form 4 detailing a pre-planned sale of 85,365 Class A Common Stock shares scheduled for August 13, 2025, under a Rule 10b5-1 trading plan.
Summary
- Amanda Gourbault, Chief Revenue Officer of CompoSecure, Inc. (CMPO), filed a Form 4 on August 14, 2025, reporting a planned transaction.
- The filing indicates a disposition (sale) of 85,365 shares of Class A Common Stock scheduled for August 13, 2025.
- The shares are to be sold at a weighted average price of $19.02 per share, with individual transactions ranging from $18.90 to $19.32.
- This transaction is being made pursuant to a Rule 10b5-1(c) trading plan, which allows insiders to set up a pre-arranged plan to sell shares.
- Following this planned transaction, Ms. Gourbault will beneficially own 799,668 shares of Class A Common Stock.
- The remaining beneficial ownership includes 218,960 directly owned shares and various tranches of Restricted Stock Units (RSUs) totaling 580,708 shares, subject to future vesting schedules and performance targets.
Sentiment
Score: 5
Explanation: Neutral. The sale is pre-planned under a 10b5-1 plan, mitigating concerns about insider sentiment. The officer retains significant beneficial ownership, including substantial future RSU vesting.
Positives
- The sale is part of a pre-arranged Rule 10b5-1 trading plan, indicating it was scheduled in advance and not based on recent non-public information, which mitigates concerns about insider sentiment.
- Ms. Gourbault retains significant beneficial ownership of 799,668 shares post-transaction, demonstrating continued alignment with shareholder interests.
- A substantial portion of her remaining holdings consists of RSUs with future vesting dates, including performance-vesting units, tying her compensation to the company's long-term performance.
Negatives
- An insider sale, even if pre-planned, reduces the direct equity ownership of a key executive, which some investors may perceive as a slight negative signal.
Risks
- NA
Future Outlook
The filing details future vesting schedules for various Restricted Stock Units (RSUs) held by the Chief Revenue Officer, with vesting dates extending to February 2032. These include time-based and performance-vesting RSUs, aligning executive incentives with long-term company performance.
Industry Context
NA
Stakeholder Impact
- Shareholders: The pre-planned nature of the sale under a 10b5-1 plan suggests the transaction is not a reaction to new, negative information, potentially reducing concerns about insider sentiment. However, a reduction in direct insider ownership could still be viewed with slight caution.
- Employees: The significant RSU holdings and their vesting schedules indicate continued long-term incentives for the Chief Revenue Officer, which can be a positive for employee morale and retention.
Next Steps
- The planned sale of 85,365 shares of Class A Common Stock is scheduled to occur on August 13, 2025.
- Various tranches of Restricted Stock Units (RSUs) will vest on specific future dates, including January 1, 2026, January 1, 2027, February 26, 2028, February 26, 2030, and February 26, 2032.
- Performance-vesting RSUs will vest over applicable performance periods based on achievement of provided targets and continued service.
Key Dates
| Date | Description |
|---|---|
| 01/01/2026 | Vesting date for 75,000 RSUs and 43,658 RSUs. Also, the first ratable vesting date for 107,129 RSUs. |
| 01/01/2027 | Second ratable vesting date for 107,129 RSUs. |
| 02/26/2028 | First of three equal installments for 63,251 RSUs. |
| 02/26/2030 | Second of three equal installments for 63,251 RSUs. |
| 02/26/2032 | Third of three equal installments for 63,251 RSUs. |
| 08/13/2025 | Scheduled transaction date for the sale of 85,365 shares of Class A Common Stock. |
| 08/14/2025 | Date the Form 4 was signed by attorney-in-fact and filed. |
Recommendation
holdThe transaction is a pre-planned sale by a key executive under a 10b5-1 plan, which typically signals a neutral event rather than a reaction to new company developments. While it reduces direct ownership, the executive retains substantial beneficial interest, including a significant number of RSUs with future vesting dates. This suggests a long-term commitment to the company's performance. The sale itself does not provide new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate for existing investors.
Keywords
CompoSecure, CMPO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Revenue Officer, Equity Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.